PLOD1 and nonpapillary renal cell carcinoma: Through integrated bioinformatic analysis and functional validation, we comprehensively characterize the biological functions and clinical translation potential of the PLOD family in ccRCC for the first time, offering new perspectives for improving patient outcomes.